Corcept Therapeutics Incorporated
CORT
$69.57
$0.751.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 133.66M | 133.99M | 141.21M | 141.82M | 125.98M |
| Total Depreciation and Amortization | 1.89M | 1.62M | 1.34M | 1.15M | 938.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.16M | 13.43M | 10.23M | 5.68M | 8.91M |
| Change in Net Operating Assets | 31.50M | 30.40M | 45.30M | -3.98M | -12.09M |
| Cash from Operations | 182.20M | 179.45M | 198.07M | 144.66M | 123.74M |
| Capital Expenditure | -1.92M | -2.28M | -2.17M | -2.05M | -453.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -39.52M | -169.49M | -175.43M | -94.10M | -161.23M |
| Cash from Investing | -41.44M | -171.76M | -177.60M | -96.15M | -161.68M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 20.66M | 11.38M | 9.62M | 8.96M | 7.83M |
| Repurchase of Common Stock | -189.05M | -78.99M | -37.97M | -31.98M | -13.67M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -168.39M | -67.61M | -28.35M | -23.02M | -5.84M |
| Foreign Exchange rate Adjustments | 1.79M | -6.00K | -6.00K | -6.00K | -6.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.84M | -59.93M | -7.89M | 25.49M | -43.79M |